UK Markets open in 35 mins

e-Therapeutics plc (ETX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
21.050.00 (0.00%)
At close: 10:05AM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 349.50
52-week low 314.50
50-day moving average 318.37
200-day moving average 329.38

Share statistics

Avg vol (3-month) 3274.65k
Avg vol (10-day) 3389.35k
Shares outstanding 5514.55M
Implied shares outstanding 6N/A
Float 8163.59M
% held by insiders 169.85%
% held by institutions 119.17%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Jan 2022
Most-recent quarter (mrq)31 Jan 2022


Profit margin 0.00%
Operating margin (ttm)-2,006.29%

Management effectiveness

Return on assets (ttm)-27.14%
Return on equity (ttm)-38.56%

Income statement

Revenue (ttm)477k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)477k
Net income avi to common (ttm)-8.07M
Diluted EPS (ttm)-1.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.65M
Total cash per share (mrq)0.05
Total debt (mrq)686k
Total debt/equity (mrq)2.45
Current ratio (mrq)19.31
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-7.8M
Levered free cash flow (ttm)-5.85M